ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Critical Care Medicine

Top Critical Care Medicine Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT WHEELER MD

Critical Care Medicine

10,653

$724K

513
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 58%

$68
Average prescription price

Avg: $186

WALEED NEMER M.D.

Critical Care Medicine

9,157

$472K

442
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 58%

$52
Average prescription price

Avg: $186

GEORGES YACOUB MD

Critical Care Medicine

4,395

$487K

617
446 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 58%

$111
Average prescription price

Avg: $186

ROBERT SCHILZ DO

Critical Care Medicine

2,080

$2.81M

112
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 58%

$1351
Average prescription price

Avg: $186

TIMOTHY KOWALSKI MD

Critical Care Medicine

2,017

$305K

268
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 58%

$151
Average prescription price

Avg: $186

JEFFREY MILLER M.D.

Critical Care Medicine

1,833

$498K

289
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 58%

$272
Average prescription price

Avg: $186

EYAD NASHAWATI M.D.

Critical Care Medicine

1,428

$446K

227
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 58%

$312
Average prescription price

Avg: $186

WILLIAM CASTALDO M.D.

Critical Care Medicine

1,405

$135K

137
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 58%

$96
Average prescription price

Avg: $186

LAWRENCE GOLDSTEIN MD

Critical Care Medicine

1,268

$358K

215
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 58%

$282
Average prescription price

Avg: $186

RITHA KARTAN MD

Critical Care Medicine

1,262

$262K

182
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 58%

$208
Average prescription price

Avg: $186

MARK SCOTT M.D.

Critical Care Medicine

1,250

$126K

109
79 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 58%

$101
Average prescription price

Avg: $186

SHABAN MAHMOUD MD

Critical Care Medicine

1,184

$129K

74
0 are 65+

92%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 58%

$109
Average prescription price

Avg: $186

GEORGE KEFALAS M.D.

Critical Care Medicine

1,182

$230K

193
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 58%

$195
Average prescription price

Avg: $186

HANY JACOB MD

Critical Care Medicine

1,172

$307K

218
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 58%

$262
Average prescription price

Avg: $186

REBECCA BAILEY MD

Critical Care Medicine

1,139

$284K

184
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 58%

$249
Average prescription price

Avg: $186

BRYAN VEYNOVICH DO

Critical Care Medicine

1,122

$312K

264
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 58%

$278
Average prescription price

Avg: $186

MANUEL BAUTISTA MD

Critical Care Medicine

984

$256K

171
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 58%

$260
Average prescription price

Avg: $186

CHADI BOU SERHAL M.D., M.S.

Critical Care Medicine

948

$188K

167
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 58%

$198
Average prescription price

Avg: $186

CHRISTOPHER SCHMITT M.D.

Critical Care Medicine

882

$123K

149
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$140
Average prescription price

Avg: $186

CHRISTOPHER ORABELLA M.D.

Critical Care Medicine

754

$107K

128
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 58%

$141
Average prescription price

Avg: $186

NIHAD BOUTROS M.D.

Critical Care Medicine

716

$217K

116
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 58%

$303
Average prescription price

Avg: $186

JAMES HEDDLESON DO

Critical Care Medicine

664

$76.3K

126
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 58%

$115
Average prescription price

Avg: $186

SANDEEP KAPUR M.D.

Critical Care Medicine

629

$73.2K

134
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 58%

$116
Average prescription price

Avg: $186

HUGO MONTENEGRO MD

Critical Care Medicine

614

$110K

92
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 58%

$179
Average prescription price

Avg: $186

RANA HEJAL MD

Critical Care Medicine

437

$77.3K

74
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 58%

$177
Average prescription price

Avg: $186

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank